Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121552) titled 'Efficacy and safety of Aipalolitoworilimab combined with docetaxel in the treatment of driver gene-negative mNSCLC after failure of first-line chemotherapy combined with immunotherapy: A prospective, single-arm clinical study' on April 1.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Henan Cancer Hospital

Condition: Primary lung cancer

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-04-01

Target Sample Size: Experimental group:47;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=300539

Publishe...